Cellular Immunity in the Peritoneum

Erscheinungsjahr 2022
ISBN: 978-0-323-99400-2
Verlag: William Andrew Publishing

Buch, Englisch, 144 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Adoptive Cell Transfer, Volume 371 in the International Review of Cell and Molecular Biology series highlights advances in the field, with this new volume presenting interesting chapters written by an international board of authors who expound on topics such as the Impact of tumor microenvironment on Adoptive Cell Transfer activity, Dendritic Cell Transfer, CAR-T Cell dysfunction and exhaustion, NK Cell-based cancer immunotherapy, Enabling CAR-T cells for solid tumors: rage against the suppressive tumor microenvironment, Improving Adoptive T-Cell therapy with cytokines administration, and What will (and should) be improved in Immunotherapy with CAR?

Zielgruppe

<p>Academic, government and industrial sectors</p>

Autoren/Hrsg.

Weitere Mitwirkende

Berraondo, Pedro

Fachgebiete

• Naturwissenschaften Biowissenschaften Molekularbiologie
• Naturwissenschaften Biowissenschaften Entwicklungsbiologie
• Naturwissenschaften Biowissenschaften Zellbiologie

Inhaltsverzeichnis

1. Macrophages Cells in the peritoneum 2. Dendritic Cells in the peritoneum 3. T Cells in the peritoneum 4. Innate immune response to peritoneal bacterial infection 5. The tumor immune microenvironment in Peritoneal Carcinomatosis 6. Immune response after intraperitoneal chemotherapy for Peritoneal Metastases 7. Omentum: Friend or foe in Ovarian Cancer immunotherapy?

Über Autor(innen)

Berraondo, Pedro
Pedro Berraondo graduated in Pharmacy at the University of Navarra in 1999. In 2004 he obtained the Ph.D. at the same university. Next, he worked at the Pasteur Institute in Paris (France) under the supervision of Dr. Claude Leclerc, where he developed novel strategies in tumor immunotherapy within the European THERAVAC project. In February 2007, he joined the Immunology and Immunotherapy Program at the Cima Universidad de Navarra, where he leads the Cytokine-based Immunotherapy laboratory. He is co-inventor of ten patents and he is co-author of more than 140 publications, including publications in Nature, Nature Medicine, Nature Reviews Drug Discovery, Immunity, Cancer Discovery, and Cancer Cell. He was certified as a full professor in 2021 by AQU. He is co-director of the degree of expert in immunooncology at the Faculty of Medicine of the University of Navarra, and is in charge of the undergraduate course of macromolecular structure at the Faculty of Sciences of the University of Navarra. He is also the coordinator of the immuno-oncology work module at CIBERONC.